Accendra Health Inc (ACH) - Total Assets
Based on the latest financial reports, Accendra Health Inc (ACH) holds total assets worth $4.04 Billion USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Accendra Health Inc for net asset value and shareholders' equity analysis.
Accendra Health Inc - Total Assets Trend (1985–2024)
This chart illustrates how Accendra Health Inc's total assets have evolved over time, based on quarterly financial data.
Accendra Health Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Accendra Health Inc's total assets of $4.04 Billion consist of 43.4% current assets and 56.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $49.38 Million | 1.1% |
| Accounts Receivable | $690.24 Million | 14.8% |
| Inventory | $1.13 Billion | 24.3% |
| Property, Plant & Equipment | $864.97 Million | 18.6% |
| Intangible Assets | $296.73 Million | 6.4% |
| Goodwill | $1.33 Billion | 28.6% |
Asset Composition Trend (1985–2024)
This chart illustrates how Accendra Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ACH market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Accendra Health Inc's current assets represent 43.4% of total assets in 2024, a decrease from 90.2% in 1985.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2024, down from 2.7% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 34.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is goodwill at 28.6% of total assets.
Accendra Health Inc Competitors by Total Assets
Key competitors of Accendra Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Accendra Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.86 | 1.09 | 1.59 |
| Quick Ratio | 0.84 | 0.45 | 0.67 |
| Cash Ratio | 0.01 | 0.00 | 0.00 |
| Working Capital | $-334.29 Million | $182.37 Million | $790.14 Million |
Accendra Health Inc - Advanced Valuation Insights
This section examines the relationship between Accendra Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -8.6% |
| Total Assets | $4.66 Billion |
| Market Capitalization | $147.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Accendra Health Inc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Accendra Health Inc's assets decreased by 8.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Accendra Health Inc (1985–2024)
The table below shows the annual total assets of Accendra Health Inc from 1985 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.66 Billion | -8.58% |
| 2023-12-31 | $5.09 Billion | -5.44% |
| 2022-12-31 | $5.39 Billion | +52.30% |
| 2021-12-31 | $3.54 Billion | +6.02% |
| 2020-12-31 | $3.34 Billion | -8.44% |
| 2019-12-31 | $3.64 Billion | -3.46% |
| 2018-12-31 | $3.77 Billion | +11.77% |
| 2017-12-31 | $3.38 Billion | +24.23% |
| 2016-12-31 | $2.72 Billion | -2.16% |
| 2015-12-31 | $2.78 Billion | +1.55% |
| 2014-12-31 | $2.74 Billion | +17.70% |
| 2013-12-31 | $2.32 Billion | +5.27% |
| 2012-12-31 | $2.21 Billion | +13.40% |
| 2011-12-31 | $1.95 Billion | +6.85% |
| 2010-12-31 | $1.82 Billion | +4.29% |
| 2009-12-31 | $1.75 Billion | -1.97% |
| 2008-12-31 | $1.78 Billion | +17.63% |
| 2007-12-31 | $1.52 Billion | -10.12% |
| 2006-12-31 | $1.69 Billion | +35.96% |
| 2005-12-31 | $1.24 Billion | +9.54% |
| 2004-12-31 | $1.13 Billion | +8.23% |
| 2003-12-31 | $1.05 Billion | +3.59% |
| 2002-12-31 | $1.01 Billion | +5.83% |
| 2001-12-31 | $953.85 Million | +9.95% |
| 2000-12-31 | $867.55 Million | +0.29% |
| 1999-12-31 | $865.00 Million | +20.51% |
| 1998-12-31 | $717.80 Million | +0.73% |
| 1997-12-31 | $712.60 Million | +4.87% |
| 1996-12-31 | $679.50 Million | -20.79% |
| 1995-12-31 | $857.80 Million | -1.24% |
| 1994-12-31 | $868.60 Million | +159.83% |
| 1993-12-31 | $334.30 Million | +21.79% |
| 1992-12-31 | $274.50 Million | -11.96% |
| 1991-12-31 | $311.80 Million | +7.44% |
| 1990-12-31 | $290.20 Million | +12.18% |
| 1989-12-31 | $258.70 Million | +36.23% |
| 1988-12-31 | $189.90 Million | +22.99% |
| 1987-12-31 | $154.40 Million | +21.77% |
| 1986-12-31 | $126.80 Million | +30.99% |
| 1985-12-31 | $96.80 Million | -- |
About Accendra Health Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. The company also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, a… Read more